Updated Jan 16, 2018

Joslyn Meier

Send Message

Designed specifically for use in the developing world, DFA’s device will enable semi-quantitative determination of two key liver enzymes, AST (aspartate transaminase) and ALT (alanine transaminase), which are routinely used to measure liver toxicity amongst patients receiving antiretroviral medications.
Designed specifically for use in the developing world, DFA’s device will enable semi-quantitative determination of two key liver enzymes, AST (aspartate transaminase) and ALT (alanine transaminase), which are routinely used to measure liver toxicity amongst patients receiving antiretroviral medications.
SEE LESS
Registered in United Statesin United States

Focus Areas:

Health

HealthSEE LESS

Milestone

Date Unknown
Created